Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Val Robertson

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
American Journal of Physical Medicine & Rehabilitation|December 31, 2004
Measuring high-level mobility after traumatic brain injuryGavin Williams, Val Robertson, Ken Greenwood
Archives of Physical Medicine and Rehabilitation|February 28, 2006
The concurrent validity and responsiveness of the high-level mobility assessment tool for measuring the mobility limitations of people with traumatic brain injuryGavin Williams, Val Robertson, Ken Greenwood, et al.
Journal of Infection in Developing Countries|May 16, 2019
A suggested algorithm for detection of multi drug-resistant tuberculosis in ZimbabweBeauty Makamure, Salome Makumbirofa, Tsitsi Bandason, et al.
The Pediatric Infectious Disease Journal|February 15, 2013
Bacteremia, causative agents and antimicrobial susceptibility among HIV-1-infected children on antiretroviral therapy in Uganda and ZimbabweVictor Musiime, Adrian Cook, Sabrina Bakeera-Kitaka, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 6, 2010
Evolution of drug resistance during 48 weeks of zidovudine/lamivudine/tenofovir in the absence of real-time viral load monitoringFred Lyagoba, David T Dunn, Deenan Pillay, et al.
Antiviral Therapy|July 21, 2012
Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA)Charles F Gilks, A Sarah Walker, David T Dunn, et al.
The Journal of Infectious Diseases|November 27, 2009
Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and zidovudine-lamivudine plus AbacavirNicaise Ndembi, Nicasie Ndembi, Ruth L Goodall, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
American Journal of Physical Medicine & Rehabilitation|December 31, 2004
Measuring high-level mobility after traumatic brain injuryGavin Williams, Val Robertson, Ken Greenwood
Archives of Physical Medicine and Rehabilitation|February 28, 2006
The concurrent validity and responsiveness of the high-level mobility assessment tool for measuring the mobility limitations of people with traumatic brain injuryGavin Williams, Val Robertson, Ken Greenwood, et al.
Journal of Infection in Developing Countries|May 16, 2019
A suggested algorithm for detection of multi drug-resistant tuberculosis in ZimbabweBeauty Makamure, Salome Makumbirofa, Tsitsi Bandason, et al.
The Pediatric Infectious Disease Journal|February 15, 2013
Bacteremia, causative agents and antimicrobial susceptibility among HIV-1-infected children on antiretroviral therapy in Uganda and ZimbabweVictor Musiime, Adrian Cook, Sabrina Bakeera-Kitaka, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|August 6, 2010
Evolution of drug resistance during 48 weeks of zidovudine/lamivudine/tenofovir in the absence of real-time viral load monitoringFred Lyagoba, David T Dunn, Deenan Pillay, et al.
Antiviral Therapy|July 21, 2012
Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA)Charles F Gilks, A Sarah Walker, David T Dunn, et al.
The Journal of Infectious Diseases|November 27, 2009
Viral rebound and emergence of drug resistance in the absence of viral load testing: a randomized comparison between zidovudine-lamivudine plus Nevirapine and zidovudine-lamivudine plus AbacavirNicaise Ndembi, Nicasie Ndembi, Ruth L Goodall, et al.
Pageof 1